Dave Duplay sits down with John L. Lehr, President & CEO of the Parkinson's Foundation, to talk about the challenges faced by those affected by Parkinson's disease, and what the Parkinson's Foundation is doing to help raise awareness and find a cure.
Health360: HealthTalk: John L. Lehr | Parkinson's Awareness Month
Parkinson’s Foundation National Medical Director Michael S. Okun, MD, speaks about actor Alan Alda revealing he has Parkinson’s and discusses Parkinson’s symptoms and treatment.
Actor Alan Alda, 82, best known for his role in M*A*S*H, revealed that he has Parkinson’s. Parkinson’s Foundation CEO John Lehr is quoted in the article. “You can live a full and productive life with the disease,” Lehr said.
The Parkinson’s Foundation recently announced the Medical University of South Carolina will become part of its Center of Excellence global network.
Business 2 Community rounded their team’s favorite brands to show the best real-life examples of a visual identity at work. The Parkinson’s Foundation is the only non-profit highlighted.
The Parkinson’s Foundation has named UI Hospitals and Clinics a center of excellence and adds it to a global network of 45 select academic medical centers.
Research suggests at least three out of 10 Ohioans have one of the 21 medical conditions that under state law can be treated with medical marijuana. Dan Davis at the Parkinson’s Foundation Ohio chapter is quoted.
According to researchers, Parkinson’s patients may experience falls because of their motor symptoms, such as uncontrollable accelerations, impaired balance, and freezing of gait. Approximately 50 percent of these falls require medical care. Data from the Parkinson’s Foundation Parkinson’s Outcomes Project is cited.
Parkinson’s Foundation Chief Scientific Officer, James Beck, PhD. Dr. Beck talks about the Parkinson’s Foundation and explains the importance of the Prevalence Project.
CTTI and the FDA recently announced patient representatives for the Patient Engagement Collaborative (PEC), a joint endeavor to gather members of the patient community to discuss new ways for patients and the FDA to work together. Parkinson’s Foundation research advocate, Anne Hall, was selected as a representative.
Parkinson’s Prevalence Project findings show that Parkinson’s impacts more people than previously thought. Parkinson’s Foundation vice president and chief scientific officer, Jim Beck, PhD, is quoted.